Przegląd Dermatologiczny

Abstract

4/2021 vol. 108
Case report

Birt-Hogg-Dubé syndrome

  1. General and Oncological Dermatology, Provincial Hospital, Opole, Poland
Dermatol Rev/Przegl Dermatol 2021, 108, 285-289
Online publish date: 2021/12/13
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Birt-Hogg-Dubé syndrome is a rare genodermatosis inherited as an autosomal dominant trait. Birt-Hogg-Dubé syndrome was first described in 1977 by three dermatologists, Arthur Birt, Georgina Hogg and William J. Dubé. It is characterised by the development of multiple small white bumps primarily occurring on the face and chest. Birt-Hogg-Dubé syndrome is associate with an increased risk or pneumothorax, pulmonary cysts, and renal tumours. The disorder is caused by mutations in the FLCN gene, which encodes folliculin.

Case report

Birt-Hogg-Dubé syndrome is a rare genodermatosis inherited as an autosomal dominant trait. Birt-Hogg-Dubé syndrome was first described in 1977 by three dermatologists, Arthur Birt, Georgina Hogg and William J. Dubé. It is characterised by the development of multiple small white bumps primarily occurring on the face and chest. Birt-Hogg-Dubé syndrome is associate with an increased risk or pneumothorax, pulmonary cysts, and renal tumours. The disorder is caused by mutations in the FLCN gene, which encodes folliculin.

Conclusions

The treatment of fibrofolliculomas in the course of Birt-Hogg-Dubé syndrome usually involves ablative laser therapy. The prognosis is good, although it depends on the patient’s general health, especially the severity of respiratory failure and the presence of renal malignancy. Patients with Birt-Hogg-Dubé syndrome require regular follow-up for pulmonary changes and renal tumors.

Share
without publication fees
without publication fees